CCND1 and cancer: For instance, miR-218 can induce cell-cycle arrest at the G1 phase by targeting the 3ʹ-UTR region of CDK6/Cyclin D1 [56], and overexpression of miR-24 increases the percentage of cells in G1 phase in HepG2 and K562 cancer cells [57].